These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10742969)
41. Exploratory or analytic meta-analysis: should we distinguish between them? Anello C; Fleiss JL J Clin Epidemiol; 1995 Jan; 48(1):109-16; discussion 117-8. PubMed ID: 7853037 [TBL] [Abstract][Full Text] [Related]
42. Comparing results of large clinical trials to those of meta-analyses. Moses LE; Mosteller F; Buehler JH Stat Med; 2002 Mar; 21(6):793-800. PubMed ID: 11870817 [TBL] [Abstract][Full Text] [Related]
43. Guidelines on How to Perform a Meta-Analysis in Spine Surgery: Strengths and Weaknesses of Design. Gendelberg D; Slattery CA; Verma K Clin Spine Surg; 2019 Feb; 32(1):30-31. PubMed ID: 30222619 [TBL] [Abstract][Full Text] [Related]
44. Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes. Curtin F; Altman DG; Elbourne D Stat Med; 2002 Aug; 21(15):2131-44. PubMed ID: 12210629 [TBL] [Abstract][Full Text] [Related]
45. Limitations and advantages of meta-analysis in clinical trials. Rockette HE; Redmond CK Recent Results Cancer Res; 1988; 111():99-104. PubMed ID: 3175314 [No Abstract] [Full Text] [Related]
46. The logic and role of meta-analysis in clinical research. Oakes M Stat Methods Med Res; 1993; 2(2):147-60. PubMed ID: 8261255 [TBL] [Abstract][Full Text] [Related]
47. Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer. Buyse M Int J Clin Oncol; 2009 Apr; 14(2):95-101. PubMed ID: 19390939 [TBL] [Abstract][Full Text] [Related]
49. Letter to the editor: a comment on Lynch et al. (2009). Lincoln TM Psychol Med; 2010 May; 40(5):877-80. PubMed ID: 19917145 [No Abstract] [Full Text] [Related]
50. Meta-analysis: the fashion of summing-up evidence. Part I. Rationale and conduct. Gelber RD; Goldhirsch A Ann Oncol; 1991 Jul; 2(7):461-8. PubMed ID: 1911452 [TBL] [Abstract][Full Text] [Related]
51. Meta-analysis in medicine. Where we are and where we want to go. Jenicek M J Clin Epidemiol; 1989; 42(1):35-44. PubMed ID: 2643675 [TBL] [Abstract][Full Text] [Related]
52. Meta-analysis of clinical trials: summary of an international conference. Boissel JP; Sacks HS; Leizorovicz A; Blanchard J; Panak E; Peyrieux JC Eur J Clin Pharmacol; 1988; 34(6):535-8. PubMed ID: 3169107 [TBL] [Abstract][Full Text] [Related]
53. Issues in meta-analysis: an overview. Bartolucci AA; Katholi CR; Singh KP; Alarcón GS Arthritis Care Res; 1994 Sep; 7(3):156-60. PubMed ID: 7727556 [TBL] [Abstract][Full Text] [Related]
54. [Introduction to meta-analytic methodology]. Nony P; Boissel JP; Lièvre M; Cucherat M; Haugh MC; Dayoub G Rev Med Interne; 1995; 16(7):536-46. PubMed ID: 7569424 [TBL] [Abstract][Full Text] [Related]
55. Randomized clinical trials in oncology. Principles and obstacles. Simon R Cancer; 1994 Nov; 74(9 Suppl):2614-9. PubMed ID: 7954274 [TBL] [Abstract][Full Text] [Related]
56. Seeing what you want to see in randomised controlled trials. Meta- analyses may suffer from interpretation bias too. Lindbaek M BMJ; 2000 Oct; 321(7268):1079. PubMed ID: 11053193 [No Abstract] [Full Text] [Related]